Position
Chief Financial Officer
Company
Viracta Therapeutics
Cardiff By The SeaInformation TechnologyBiotechnologyHealth CareScience And EngineeringDescription
Viracta Therapeutics, Inc announced the appointment of Michael Faerm as Chief Financial Officer. Mr Faerm, a seasoned biotech executive with over 25 years of experience, is expected to play a key role in supporting the company's next phase of development.
Quick answer
Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer (May 14, 2024). Viracta Therapeutics is based in Cardiff By The Sea, California, United States.
- Who is the new Chief Financial Officer at Viracta Therapeutics?
- Viracta Therapeutics named Michael Faerm Chief Financial Officer, announced May 14, 2024.
- What did Viracta Therapeutics announce on May 14, 2024?
- Viracta Therapeutics, Inc announced the appointment of Michael Faerm as Chief Financial Officer. Mr Faerm, a seasoned biotech executive with over 25 years of experience, is expected to play a key role in supporting the company's next phase of development.
- What does Viracta Therapeutics do?
- Viracta is a precision oncology company targeting virus-associated malignancies.
- Where is Viracta Therapeutics based?
- Viracta Therapeutics is based in Cardiff By The Sea, California, United States.
- Which similar companies made leadership changes around the same time?
- Zephyr AI, Inc. (May 16, 2024), Unlearn (May 16, 2024), Aprea Therapeutics (May 2, 2024) and Electra Therapeutics (May 1, 2024) also announced leadership changes within 45 days of Viracta Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Zephyr AI Appoints John Applegate as Chief Financial Officer (May 16, 2024)
- Unlearn Appoints Steve Herne as Chief Commercial Officer (May 16, 2024)
- Aprea Therapeutics Appoints Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer (May 2, 2024)
- Electra appoints Kellyn Blossom as Head of Communications and Policy in Washington, D.C. (May 1, 2024)
- Lixte Biotechnology Holdings Appoints Dr. Jan Schellens as Chief Medical Officer (June 5, 2024)
- Exscientia Appoints John P. Overington as Chief Technology Officer and Marie-Louise Fjällskog, M.D., Ph.D., as Interim Chief Medical Officer (June 6, 2024)
Who to call at Viracta Therapeutics, and when
A new leader at Viracta Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Viracta Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Viracta Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Viracta Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Viracta Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Viracta Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.